Showing results (391-400 of 1,545) with videos related to

Sort By:
Pageof 155
Chemical Communications (Cambridge, England)|March 27, 2018
Correction: Jadomycins, put a bigger ring in it: isolation of seven- to ten-membered ring analoguesStephanie M Forget, Camilo F Martinez-Farina, David L Jakeman
Reproductive Health|January 29, 2018
Quality of care during childbirth in Tanzania: identification of areas that need improvementAndrea Solnes Miltenburg, Richard Forget Kiritta, Tarek Meguid, et al.
Ecological Applications : a Publication of the Ecological Society of America|February 4, 2020
Modifications of the rain forest frugivore community are associated with reduced seed removal at the community levelOlivier Boissier, François Feer, Pierre-Yves Henry, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 7, 2022
Isolation and Maintenance of Tumor-Infiltrating Lymphocytes for Translational and Clinical Applications: Established Methods and New DevelopmentsOrenthial J Fulbright, Marie-Andrée Forget, Cara Haymaker, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 1, 1987
Lactulose-rhamnose intestinal permeability in children with cystic fibrosisJ Leclercq-Foucart, P P Forget, J L Van Cutsem
Plos One|December 5, 2024
Pharmacological interventions for remifentanil-induced hyperalgesia: A systematic review and network meta-analysis of preclinical trialsMia E Koponen, Emily Naray, Tim G Hales, et al.
Regional Anesthesia and Pain Medicine|June 3, 2026
Gut microbiome profiles in patients with nociceptive pain, neuropathic pain, and pain-free controls: a case-control studyLisa Goudman, Doris Vandeputte, Patrice Forget, et al.
European Journal of Cell Biology|December 1, 1992
Modifications of the binding properties of the human VIP receptor of IGR39 cells by sulfhydryl reagentsF Fouchier, P Forget, P Pic, et al.
Journal of Clinical Medicine|July 15, 2020
Feasibility and Preliminary Effectiveness of a Tele-Prehabilitation Program in Esophagogastric Cancer PatientsElise Piraux, Gilles Caty, Gregory Reychler, et al.
Pharmacoeconomics|March 6, 2007
Enzyme replacement therapy in orphan and ultra-orphan diseases: the limitations of standard economic metrics as exemplified by Fabry-Anderson diseaseDavid F Moore, Markus Ries, Evelyn L Forget, et al.
Pageof 155